Director, Adolescent and Young Adult Mood Disorders Inpatient Service
Director,University Mental Health Services
Main Office Address
The Johns Hopkins Hospital
600 North Wolfe St.
Baltimore, MD 21287-5371
University of Wisconsin School of Medicine
General Medicine and Psychiatry Internship
Johns Hopkins Bayview Medical Center
Adult Psychiatry Residency
Johns Hopkins Hospital
Child and Adolescent Psychiatry Fellowship
University of Pittsburgh School of Medicine
Mood disorders with a particular interest in adolescent and young adult health. Also interested in medical and community education. Principal investigator of an NIMH funded, multi-site study on adolescents at risk for familial Bipolar Disorder.
Hess SG, Cox TS, Gonzales LC, Kastelic EA, Mink SP, Rose LE, Swartz KL. A survey of adolescents' knowledge about depression. Arch Psychiatr Nurs. 2004 Dec;18(6):228-34.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004 Aug 18;292(7):807-20.
Pediatric Psychopharmacology. 2003, Oxford: University Press. Walkup JT, Ritter-Welzant J., Kastelic EA., Joshi N., Frosch E., Antidepressants III: Other Agents, Chapter 24: 295-308.
Riddle MA, Kastelic EA, and Frosch E. Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry and Allied Disciplines 2001, 42(1): 73-90.
Kastelic EA, Labellarte MJ, and Riddle MA. Selective reuptake inhibitors for children and adolescents. Current Psychiatry Reports 2000, 2: 117-121.